ISSN:

Journal Home

Neuropsychopharmacology Reports Q2 Unclaimed

John Wiley & Sons Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neuropsychopharmacology Reports is a journal indexed in SJR in Pharmacology and Psychiatry and Mental Health with an H index of 24. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2052 €. The scope of the journal is focused on psychopharmacology, neurology, neuropsychology, psychiatry, pharmacology. It has an SJR impact factor of 0,602 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,602.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Clinical Psychology (Q2) Pharmacology (Q2) Pharmacology (medical) (Q2) Pharmacology (medical) (Q2) Psychiatry and Mental Health (Q3)

Price

2052 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,602

SJR Impact factor

24

H Index

108

Total Docs (Last Year)

218

Total Docs (3 years)

3606

Total Refs

461

Total Cites (3 years)

217

Citable Docs (3 years)

1.73

Cites/Doc (2 years)

33.39

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Vascular Pharmacology Q2
AIDS Research and Therapy Q2
Drug Safety - Case Reports Q2
Expert Review of Anticancer Therapy Q2
Toxicology and Applied Pharmacology Q2

Compare this journals

Aims and Scope

Psychopharmacology Neurology Neuropsychology Psychiatry Pharmacology